Friday, March 8, 2024 Promising Outcomes with HIV Treatment Started Promptly After Birth: Deborah Persaud Presents at CROI 2024 (VIDEO) Deborah Persaud of Johns Hopkins University School of Medicine and NIAID's Catey Laube at CROI 2024. Credit: HIV.gov. On the final day of the 2024 Conference on Retroviruses and Opportunistic Infections, HIV.gov spoke with Deborah Persaud, M.D., professor of Pediatrics at the Johns Hopkins University School of Medicine and director of the Division of Pediatric Infectious Diseases at Johns Hopkins Children's Center, who presented a study in which four children remained free of detectable HIV for more than one year after their antiretroviral therapy was paused to see if they could achieve HIV remission. Dr. Persaud spoke with Catey Laube of NIAID's Office of Communications and Government Relations. Watch their conversation. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107